Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-cash Items (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Non-cash Items for 2 consecutive years, with $14.3 million as the latest value for Q4 2020.

  • On a quarterly basis, Non-cash Items rose 177.29% to $14.3 million in Q4 2020 year-over-year; TTM through Dec 2020 was $14.3 million, a 177.29% increase, with the full-year FY2020 number at $14.3 million, up 177.29% from a year prior.
  • Non-cash Items was $14.3 million for Q4 2020 at Pliant Therapeutics, up from $629988.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $14.3 million in Q4 2020 to a low of $70079.0 in Q2 2020.